Gerresheimer held a groundbreaking ceremony at its glass facility in in Querétaro, Mexico to celebrate the start of construction for its plant expansion.
The pharmaceutical and cosmetics glass manufacturer will invest approximately €100 million in a new building and new production lines at its Querétaro plant.
This will increase its manufacturing capacity for syringes for the North American market by several hundred million “ready-to-fill” (RTF) syringes annually.
The 7,500 m² building is expected to be completed by mid-2024 and production is anticipated to start in the second quarter of 2025.
Dietmar Siemssen, CEO of Gerresheimer AG, said: “Our plant in Querétaro will enable us to supply the entire North American trading area with high-quality syringes that are also suitable for biopharmaceuticals. Now we are once again significantly expanding production capacity for contracts we have already concluded.”
Plans for the new production building include 10 glass-forming machines and several needle assembly and RTF production lines.
The latest automation and quality assurance technology will be used.
The expansion will also allow Gerresheimer to create around 270 new jobs at the Querétaro plant, where around 1,000 people are currently employed.
In addition to syringes, Gerresheimer produces injection vials, cartridges, and ampoules at the site.
The manufacturer is also currently expanding its production capacities for various product segments in Germany, Belgium, North Macedonia, the Czech Republic, and the United States.
